Read More

This 7% Yielding ETF Was Ravaged By Ukraine War. Is Now The Time To Buy?

The iShares MSCI Germany Index Fund is down roughly 39% year-to-date, after hitting a high of $33.51 back in January 2022. The steepest decline in the exchange traded fund took place shortly after Russia decided to mobilize its troops into Ukraine as a “specialty military operation,” which took place in February 2022.


Read More

Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage

Biomind Labs Inc. (OTC: BMNDF), a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary drug BMND01 for the Treatment-Resistant Depression (TDR) disorder.